Biotech News & Trading Forum: Community User: Weedmaster

👍

https://fintel.io/so/us/aqst

Waverley Pharma (WAVE.V) Kurs 0.16 / Marktkap C$ 9 million / 5 Krebsmedikamente seit kurzem in Europa Zugelassen weitere 2 MEGA Krebsmedikamente kurz vor US und Europa Zulassung im Q4 erwartet = UNBEKANNTE Aktie mit MASSIV Upside Potenzial möglicher 20 Bagger und mehr aufgrund der mickrigen Marktkap ... https://www.waverleypharma.com/generic-product-pipeline.html

http://stocktwits.com/Valuable_Trades/message/237841290

https://www.benzinga.com/pressreleases/20/08/g17170070/aquestive-therapeutics-initiates-phase-1-pharmacokinetic-trial-of-aqst-108-sublingual-film-formula

CODX bereit für den Rebound🤔 https://www.proactiveinvestors.com/companies/news/926958/co-diagnostics-notes-its-technology-to-analyze-self-administered-coronavirus-tests-for-los-angeles-school-system-926958.html?theme=2&_v=1&color=1&hl=en&sp=1

👋

Hey Leute,hab mir mal BiolineRX ins Depot gelegt.Liest sich alles recht stimmig und scheint interessant für die Zukunft zu sein🍀 @Gottsbrain Danke Dir

Fleißig fleißig Freunde! 😁🌶

Chimerix Expected Upcoming Milestones Completion of NDA submission of BCV mid-2020 Completion of Phase 2 portion of DSTAT trial in COVID-19 in second half of 2020 Initiation of Phase 3 trial of DSTAT in first line AML Potential procurement agreement for BCV prior to FDA decision on smallpox NDA  FDA decision on BCV smallpox NDA in 2021 Completion of manufacturing of approximately $100 million of BCV product for SNS by mid-2021. Chimerix's balance sheet at March 31, 2020 included $103.0 million of capital available to fund operations, no debt, and approximately 61.9 million outstanding shares of common stock.  The Company expects to end the year with approximately $70 million in cash and cash equivalents at the end of 2020.

https://ir.biolinerx.com/node/12161/html

https://finance.yahoo.com/news/zosano-pharma-announces-agreement-collaborate-123000134.html

Corbus Pharmaceuticals CRBP nach Offering für 7,70$ ist jetzt Cadh bis Q3/2021 vorhanden. 2 Catalysts in den nächsten 6 Wochen: Phase 3 Resunab - RESOLVE-1 Systemic Sclerosis Sommer 2020 Phase 2 Lenabasum Cystic Fibrosis in Q3 3 Analystenratings von 32 bis 112$. https://www.benzinga.com/pressreleases/20/08/g16962158/corbus-pharmaceuticals-reports-second-quarter-financial-results-and-corporate-updates

Ob Novabay wieder so durchstartet wie bei der letzten Amazon News🤔🤔 https://www.benzinga.com/pressreleases/20/08/b17134315/novabay-expands-avenovas-online-distribution

https://finance.yahoo.com/news/adamis-pharmaceuticals-announces-second-quarter-204000268.html

.